These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 30738983)

  • 41. Disease outcome may be predicted by molecular detection of minimal residual disease in bone marrow in advanced neuroblastoma: a pilot study.
    Fukuda M; Miyajima Y; Miyashita Y; Horibe K
    J Pediatr Hematol Oncol; 2001 Jan; 23(1):10-3. PubMed ID: 11196262
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Patterns of Relapse in High-Risk Neuroblastoma Patients Treated With and Without Total Body Irradiation.
    Li R; Polishchuk A; DuBois S; Hawkins R; Lee SW; Bagatell R; Shusterman S; Hill-Kayser C; Al-Sayegh H; Diller L; Haas-Kogan DA; Matthay KK; London WB; Marcus KJ
    Int J Radiat Oncol Biol Phys; 2017 Feb; 97(2):270-277. PubMed ID: 28068235
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Dose-escalation is needed for gross disease in high-risk neuroblastoma.
    Casey DL; Kushner BH; Cheung NV; Modak S; LaQuaglia MP; Wolden SL
    Pediatr Blood Cancer; 2018 Jul; 65(7):e27009. PubMed ID: 29469198
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Spot-scanning proton radiation therapy for recurrent, residual or untreated intracranial meningiomas.
    Weber DC; Lomax AJ; Rutz HP; Stadelmann O; Egger E; Timmermann B; Pedroni ES; Verwey J; Miralbell R; Goitein G;
    Radiother Oncol; 2004 Jun; 71(3):251-8. PubMed ID: 15172139
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A Prospective Outcomes Study of Proton Therapy for Chordomas and Chondrosarcomas of the Spine.
    Indelicato DJ; Rotondo RL; Begosh-Mayne D; Scarborough MT; Gibbs CP; Morris CG; Mendenhall WM
    Int J Radiat Oncol Biol Phys; 2016 May; 95(1):297-303. PubMed ID: 27084648
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Pencil beam scanning proton therapy for treatment of the retroperitoneum after nephrectomy for Wilms tumor: A dosimetric comparison study.
    Vogel J; Lin H; Both S; Tochner Z; Balis F; Hill-Kayser C
    Pediatr Blood Cancer; 2017 Jan; 64(1):39-45. PubMed ID: 27565764
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Early outcomes of breast cancer patients treated with post-mastectomy uniform scanning proton therapy.
    Luo L; Cuaron J; Braunstein L; Gillespie E; Kahn A; McCormick B; Mah D; Chon B; Tsai H; Powell S; Cahlon O
    Radiother Oncol; 2019 Mar; 132():250-256. PubMed ID: 30414757
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Intraoperative radiation therapy for advanced neuroblastoma: the problem of securing the IORT field.
    Sugito K; Kusafuka T; Hoshino M; Inoue M; Goto H; Ikeda T; Hagiwara N; Koshinaga T; Fukuzawa M; Nakamura M; Shichino H; Chin M; Mugishima H; Saito T; Tanaka Y
    Pediatr Surg Int; 2007 Dec; 23(12):1203-7. PubMed ID: 17968560
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Long-Term Clinical Safety of High-Dose Proton Radiation Therapy Delivered With Pencil Beam Scanning Technique for Extracranial Chordomas and Chondrosarcomas in Adult Patients: Clinical Evidence of Spinal Cord Tolerance.
    Stieb S; Snider JW; Placidi L; Kliebsch U; Lomax AJ; Schneider RA; Weber DC
    Int J Radiat Oncol Biol Phys; 2018 Jan; 100(1):218-225. PubMed ID: 29029887
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Efficacy and Feasibility of Proton Beam Therapy in Relapsed High-Risk Neuroblastoma-Experiences from the Prospective KiProReg Registry.
    Jazmati D; Hero B; Thole-Kliesch TM; Merta J; Deubzer HE; Bäumer C; Heinzelmann F; Schleithoff SS; Koerber F; Eggert A; Schwarz R; Simon T; Timmermann B
    Curr Oncol; 2022 Oct; 29(11):8222-8234. PubMed ID: 36354709
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Patterns of failure and toxicity profile following proton beam therapy for pediatric bladder and prostate rhabdomyosarcoma.
    Buszek SM; Ludmir EB; Grosshans DR; McAleer MF; McGovern SL; Harrison DJ; Okcu MF; Chintagumpala MM; Mahajan A; Paulino AC
    Pediatr Blood Cancer; 2019 Nov; 66(11):e27952. PubMed ID: 31397065
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Proton Beam Reirradiation for Recurrent Head and Neck Cancer: Multi-institutional Report on Feasibility and Early Outcomes.
    Romesser PB; Cahlon O; Scher ED; Hug EB; Sine K; DeSelm C; Fox JL; Mah D; Garg MK; Han-Chih Chang J; Lee NY
    Int J Radiat Oncol Biol Phys; 2016 May; 95(1):386-395. PubMed ID: 27084656
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Proton radiation therapy for pediatric medulloblastoma and supratentorial primitive neuroectodermal tumors: outcomes for very young children treated with upfront chemotherapy.
    Jimenez RB; Sethi R; Depauw N; Pulsifer MB; Adams J; McBride SM; Ebb D; Fullerton BC; Tarbell NJ; Yock TI; Macdonald SM
    Int J Radiat Oncol Biol Phys; 2013 Sep; 87(1):120-6. PubMed ID: 23790826
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Outcome prediction by molecular detection of minimal residual disease in bone marrow for advanced neuroblastoma.
    Horibe K; Fukuda M; Miyajima Y; Matsumoto K; Kondo M; Inaba J; Miyashita Y
    Med Pediatr Oncol; 2001 Jan; 36(1):203-4. PubMed ID: 11464885
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Outcomes following proton therapy for pediatric ependymoma.
    Indelicato DJ; Bradley JA; Rotondo RL; Nanda RH; Logie N; Sandler ES; Aldana PR; Ranalli NJ; Beier AD; Morris CG; Mendenhall NP
    Acta Oncol; 2018 May; 57(5):644-648. PubMed ID: 29239262
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Intensity modulated radiation therapy provides excellent local control in high-risk abdominal neuroblastoma.
    Pai Panandiker AS; Beltran C; Billups CA; McGregor LM; Furman WL; Davidoff AM
    Pediatr Blood Cancer; 2013 May; 60(5):761-5. PubMed ID: 23024112
    [TBL] [Abstract][Full Text] [Related]  

  • 57. N-Myc gene amplification is a major prognostic factor in localized neuroblastoma: results of the French NBL 90 study. Neuroblastoma Study Group of the Société Francaise d'Oncologie Pédiatrique.
    Rubie H; Hartmann O; Michon J; Frappaz D; Coze C; Chastagner P; Baranzelli MC; Plantaz D; Avet-Loiseau H; Bénard J; Delattre O; Favrot M; Peyroulet MC; Thyss A; Perel Y; Bergeron C; Courbon-Collet B; Vannier JP; Lemerle J; Sommelet D
    J Clin Oncol; 1997 Mar; 15(3):1171-82. PubMed ID: 9060561
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Pencil Beam Scanning Proton Beam Chemoradiation Therapy With 5-Fluorouracil and Mitomycin-C for Definitive Treatment of Carcinoma of the Anal Canal: A Multi-institutional Pilot Feasibility Study.
    Wo JY; Plastaras JP; Metz JM; Jiang W; Yeap BY; Drapek LC; Adams J; Baglini C; Ryan DP; Murphy JE; Parikh AR; Allen JN; Clark JW; Blaszkowsky LS; DeLaney TF; Ben-Josef E; Hong TS
    Int J Radiat Oncol Biol Phys; 2019 Sep; 105(1):90-95. PubMed ID: 31128146
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Locoregional tumor progression after radiation therapy influences overall survival in pediatric patients with neuroblastoma.
    Pai Panandiker AS; McGregor L; Krasin MJ; Wu S; Xiong X; Merchant TE
    Int J Radiat Oncol Biol Phys; 2010 Mar; 76(4):1161-5. PubMed ID: 19679408
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Differentiated thyroid carcinoma after 131I-MIBG treatment for neuroblastoma during childhood: description of the first two cases.
    van Santen HM; Tytgat GA; van de Wetering MD; van Eck-Smit BL; Hopman SM; van der Steeg AF; Nieveen van Dijkum EJ; van Trotsenburg AS
    Thyroid; 2012 Jun; 22(6):643-6. PubMed ID: 22524499
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.